£1.0M
The company has obtained capital from the NHS England funded initiative to support pre-clinical development.
Chondrogenix
Chondrogenix develops regenerative cartilage therapy for osteoarthritis patients.
£1.0MTotal raised
Chondrogenix is a biotechnology company developing regenerative cartilage therapy for the treatment of osteoarthritis. The firm uses a data driven conversion platform to generate a scalable source of therapeutic cells.
Categories
Team
WK
Wael Kafienah
Director